Hu Yu-Lian, Lin Qiang, Li Yan, Zheng Xing-Hai
Obstetrics and Gynecology Department, Rizhao People's Hospital, Rizhao 276826, Shandong Province, China.
Zhongguo Zhen Jiu. 2011 Aug;31(8):683-6.
To observe the clinical curative effect of primary dysmenorrhea and the content of prostaglandin F2alpha (PGF2alpha) in peripheral blood of menstrual periods treated with eye acupuncture therapy.
One hundred and ten cases of primary dysmenorrhea were randomly divided into an eye acupuncture group (60 cases) and a medication group (50 cases). In eye acupuncture group, low energizer area, liver area, kidney area, heart area and spleen area etc. were selected according to the differentiation, and the eye acupuncture therapy was applied. In medication group, Ibuprofen Sustained Release Capsules was taken with oral administration for 300 mg 1-2 days before menses coming or when the symptoms appeared, once every 12 hours, for 3-5 days totally. Three menstrual periods made one session. The content of PGF2alpha in peripheral blood, and the curative effects and recurrence 3 and 6 months after treatment were observed.
After 3 months treatment, compared with the curative effects between both groups, the cured rate was 55.0% (33/60) and the total effective rate was 95.0% (57/60) in eye acupuncture group, which were superior to those of 34.0% (17/50) and 82.0% (41/50) in medication group (both P < 0.05). According to the following-up after 6 menstrual periods, the recurrence rate was 9.1% (3/33), inferior to that of 35.3% (6/11) in medication group. The contents of PGF2alpha in peripheral blood of menstrual periods were all reduced after treatment in two groups (both P < 0.01).
The curative effect of primary dysmenorrhea treated with eye acupuncture is favorable, and the lever of PGF2alpha in peripheral blood of menstrual periods is reduced.
观察眼针疗法治疗原发性痛经的临床疗效及经期外周血中前列腺素F2α(PGF2α)的含量变化。
将110例原发性痛经患者随机分为眼针组(60例)和药物组(50例)。眼针组根据辨证选取下焦区、肝区、肾区、心区、脾区等,施以眼针疗法。药物组于月经来潮前1 - 2天或出现症状时口服布洛芬缓释胶囊300mg,每12小时1次,共服用3 - 5天。以三个月经周期为1个疗程。观察两组治疗后经期外周血PGF2α含量、疗效及治疗后3个月、6个月的复发情况。
治疗3个月后,眼针组治愈率为55.0%(33/60),总有效率为95.0%(57/60),均优于药物组的34.0%(17/50)和82.0%(41/50)(P均<0.05)。经6个月经周期随访,眼针组复发率为9.1%(3/33),低于药物组的35.3%(6/11)。两组治疗后经期外周血PGF2α含量均降低(P均<0.01)。
眼针疗法治疗原发性痛经疗效良好,可降低经期外周血中PGF2α水平。